# CSAD

## Overview
The CSAD gene encodes the enzyme cysteine sulfinic acid decarboxylase, which is a pyridoxal phosphate-dependent decarboxylase (PLP-DC) involved in the biosynthesis of taurine, a vital amino acid in mammals. This enzyme catalyzes the conversion of cysteine sulfinic acid to hypotaurine, which is subsequently oxidized to taurine, playing a significant role in various physiological processes such as osmoregulation, membrane stabilization, and neuromodulation. Structurally, the enzyme is characterized by a conserved fold typical of PLP-DCs, with a dimeric quaternary structure that is essential for its catalytic function. The CSAD gene's expression is notably significant in the brain, particularly in neurons and astrocytes, underscoring its importance in neurological functions. Alterations in CSAD expression have been implicated in pathological conditions such as hepatocellular carcinoma, highlighting its potential as a biomarker for liver cancer (Mahootchi2021Structure; KISHIMOTO1997Overexpression).

## Structure
The cysteine sulfinic acid decarboxylase (CSAD) enzyme is involved in taurine biosynthesis and exhibits a complex molecular structure. The primary structure of CSAD consists of a sequence of amino acids encoded by the CSAD gene. The secondary structure includes alpha helices and beta sheets, which contribute to the enzyme's overall stability and function (Mahootchi2021Structure).

The tertiary structure of CSAD reveals a conserved fold typical of pyridoxal phosphate-dependent decarboxylases (PLP-DCs), with the active site fully occupied by pyridoxal phosphate (PLP) covalently attached to Lys305, indicating a catalytically competent form (Mahootchi2021Structure). The active site is characterized by a high positive charge, which is crucial for attracting negatively charged substrates like cysteine sulphinic acid (CSA) (Mahootchi2021Structure).

In terms of quaternary structure, CSAD primarily exists as a dimer, with the active site formed at the dimer interface. This dimerization is of high affinity, as no monomeric form was detected (Mahootchi2021Structure). The enzyme's structure also includes a flexible loop covering the active site, which is important for the decarboxylation reaction and involves key residues such as Tyr335 (Mahootchi2021Structure). The presence of a chloride ion in the active site may assist in substrate recognition (Mahootchi2021Structure).

## Function
Cysteine sulfinic acid decarboxylase (CSAD) is an enzyme that plays a crucial role in the biosynthesis of taurine, the most abundant free amino acid in mammals. CSAD catalyzes the decarboxylation of cysteine sulfinic acid (CSA) to hypotaurine, which is subsequently oxidized to taurine. This process is part of a three-step pathway starting from cysteine (Mahootchi2021Structure). Taurine is involved in various physiological functions, including maintaining osmotic pressure, structural integrity of biological membranes, and acting as a neuromodulator in the nervous system (Mahootchi2021Structure; Wen1996Multiplicity).

CSAD is a pyridoxal 5´-phosphate (PLP)-dependent enzyme, and its activity is essential for maintaining adequate taurine levels. It is expressed in neurons and astrocytes, particularly in the cerebellum and hippocampus, indicating its importance in brain function (Winge2015Mammalian; Mahootchi2021Structure). The enzyme's active site is characterized by a high positive charge, which is important for attracting negatively charged substrates like CSA (Mahootchi2021Structure). CSAD's activity is crucial for normal physiological processes, and deficiencies in this enzyme can lead to significant physiological consequences, as observed in CSAD-deficient models (Mahootchi2021Structure).

## Clinical Significance
Alterations in the expression of the CSAD gene have been linked to the development of hepatocellular carcinoma (HCC) in rats. During hepatocarcinogenesis, CSAD expression is initially downregulated but significantly increases in precancerous and cancerous states, suggesting its potential as a genetic marker for liver cancer development (KISHIMOTO1997Overexpression). The overexpression of CSAD in rat liver during hepatocarcinogenesis is associated with the production of autoantibodies against CSAD, indicating its high antigenicity and potential role in autoimmunity during liver cancer progression (KISHIMOTO1997Overexpression). Sera from HCC-bearing rats show significantly elevated levels of anti-CSAD antibodies, with titers 30 to 200 times higher than in normal rats, suggesting a strong immune response linked to CSAD overexpression (KISHIMOTO1997Overexpression).

In addition to its role in cancer, CSAD is involved in taurine synthesis, which is crucial for bile acid conjugation and other physiological functions. Disruptions in CSAD expression can affect taurine production and bile acid metabolism, potentially impacting liver function and metabolic homeostasis (Wang2018HNF4α; Kerr2013Cysteine). However, specific diseases or conditions directly resulting from CSAD mutations in humans are not detailed in the provided context.


## References


[1. (Wang2018HNF4α) Yifeng Wang, David Matye, Nga Nguyen, Yuxia Zhang, and Tiangang Li. Hnf4α regulates csad to couple hepatic taurine production to bile acid synthesis in mice. Gene Expression, 18(3):187–196, August 2018. URL: http://dx.doi.org/10.3727/105221618X15277685544442, doi:10.3727/105221618x15277685544442. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3727/105221618X15277685544442)

[2. (Mahootchi2021Structure) Elaheh Mahootchi, Arne Raasakka, Weisha Luan, Gopinath Muruganandam, Remy Loris, Jan Haavik, and Petri Kursula. Structure and substrate specificity determinants of the taurine biosynthetic enzyme cysteine sulphinic acid decarboxylase. Journal of Structural Biology, 213(1):107674, March 2021. URL: http://dx.doi.org/10.1016/j.jsb.2020.107674, doi:10.1016/j.jsb.2020.107674. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jsb.2020.107674)

[3. (Wen1996Multiplicity) Xiao Wen Tang, Che-Chang Hsu, Yong Sun, Elliott Wu, Chai-Yuh Yang, and Jang-Yen Wu. Multiplicity of brain cysteine suif inic acid decarboxylase - purification, characterization and subunit structure. Journal of Biomedical Science, 3(6):422–453, 1996. URL: http://dx.doi.org/10.1159/000456950, doi:10.1159/000456950. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1159/000456950)

[4. (KISHIMOTO1997Overexpression) T KISHIMOTO, K KOKURA, T NAKADAI, Y MIYAZAWA, T WAKAMATSU, Y MAKINO, T NAKAMURA, E HARA, K ODA, and M MURAMATSU. Overexpression of cysteine sulfinic acid decarboxylase stimulated by hepatocarcinogenesis results in autoantibody production in rats. Hepatology Research, 7(1):68–68, May 1997. URL: http://dx.doi.org/10.1016/s0928-4346(97)89835-0, doi:10.1016/s0928-4346(97)89835-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0928-4346(97)89835-0)

[5. (Kerr2013Cysteine) Thomas A. Kerr, Yuri Matsumoto, Hitoshi Matsumoto, Yan Xie, Lawrence L. Hirschberger, Martha H. Stipanuk, Sayeepriyadarshini Anakk, David D. Moore, Mitsuhiro Watanabe, Susan Kennedy, and Nicholas O. Davidson. Cysteine sulfinic acid decarboxylase regulation: a role for farnesoid <scp>x</scp> receptor and small heterodimer partner in murine hepatic taurine metabolism. Hepatology Research, October 2013. URL: http://dx.doi.org/10.1111/hepr.12230, doi:10.1111/hepr.12230. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/hepr.12230)

[6. (Winge2015Mammalian) Ingeborg Winge, Knut Teigen, Agnete Fossbakk, Elaheh Mahootchi, Rune Kleppe, Filip Sköldberg, Olle Kämpe, and Jan Haavik. Mammalian csad and gadl1 have distinct biochemical properties and patterns of brain expression. Neurochemistry International, 90:173–184, November 2015. URL: http://dx.doi.org/10.1016/j.neuint.2015.08.013, doi:10.1016/j.neuint.2015.08.013. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neuint.2015.08.013)